1. Overview
Folate (Folic Acid), also known as vitamin B9, is a water-soluble B-complex vitamin essential for DNA synthesis, cell division, and normal cellular growth. It exists naturally in food as folate and in synthetic form as folic acid. Folate plays a crucial role in red blood cell formation, brain function, and overall cellular metabolism.
Adequate folate intake is particularly important during pregnancy, as it significantly reduces the risk of neural tube defects involving the brain and spinal cord. Serum folate levels reflect recent dietary intake, whereas erythrocyte (RBC) folate levels provide a more accurate assessment of long-term tissue stores.
2. Symptoms
Folate deficiency does not directly produce symptoms initially but leads to characteristic clinical manifestations over time. Common features include megaloblastic anemia, weakness, fatigue, irritability, pallor, shortness of breath, and cognitive changes.
Additional symptoms may include mouth ulcers, gastritis, nausea, abdominal pain, altered taste perception, and neurological complaints. In pregnant women, folate deficiency is associated with neural tube defects in the developing fetus. Laboratory findings often show anemia with an increased mean corpuscular volume (MCV) and neutropenia.
3. Causes
Low Folic acid levels arise from inadequate dietary intake, impaired absorption, increased requirements, or interference with metabolism. Causes include poor nutrition, chronic alcoholism, malabsorption syndromes such as celiac disease and Crohn’s disease, gastrointestinal surgeries, chronic illnesses, and excessive urinary losses seen in kidney disease or dialysis.
Certain medications act as folic acid antagonists and reduce folate availability, including methotrexate, anticonvulsants, sulfasalazine, trimethoprim, antimalarials, oral contraceptives, and heavy use of antacids. Increased physiological demand during pregnancy, lactation, infancy, adolescence, and hemolytic anemia also contributes to folate depletion. Genetic variants such as MTHFR mutations and concurrent vitamin B12 deficiency further impair folate metabolism.
4. Risk Factors
Individuals at higher risk of folate deficiency include those with poor dietary habits, chronic alcohol use, gastrointestinal disorders, malabsorption syndromes, and chronic systemic illnesses. Pregnant women and women of childbearing age have increased folate requirements and are at greater risk of deficiency if intake is inadequate.
Patients receiving folate-antagonist medications or undergoing cancer therapy are also susceptible. Low folate levels are associated with elevated homocysteine, which increases cardiovascular risk. Interpretation of folate status must consider both serum and RBC folate levels to distinguish between acute and chronic deficiency.
5. Prevention and Clinical Management
Folic acid assessment is indicated in patients with unexplained anemia, megaloblastic anemia, neurological symptoms, malabsorption disorders, poor dietary intake, alcoholism, pregnancy, and during monitoring of folate therapy.
Blood samples for serum folate are collected in a red-cap tube, with serum separated promptly. Serum folate is stable for a limited time at ambient or refrigerated conditions and should be transported frozen if delayed. RBC folate testing requires EDTA samples protected from light and reflects long-term tissue stores.
Folic acid levels can be measured using competitive binding immunoassays, microbiological assays (Lactobacillus casei), liquid chromatography–mass spectrometry, and quantitative chemiluminescence immunoassays. Reference ranges vary by age and population, with deficiency generally defined as serum folate below 2.2 ng/mL and borderline levels between 2.2 and 3.0 ng/mL.
Clinically, serum folate is useful for detecting recent deficiency and nutritional status, while RBC folate is preferred for assessing chronic deficiency and pregnancy-related risk. Folate supplementation is central to the treatment of megaloblastic anemia, prevention of neural tube defects, and correction of deficiency due to malnutrition or malabsorption.
Beyond hematologic health, folate plays an important role in cardiovascular protection by lowering homocysteine levels, supports cognitive function (especially in combination with vitamin B12), and serves as an adjunctive therapy with methotrexate to reduce drug toxicity. Monitoring folate levels helps guide therapy, assess compliance, and prevent long-term complications.
